Route: Intramuscular (IM), Intravenous (IV) or Subcutaneous (SC)
Anything else is a gamble
While these procedures can provide long-term improvement when performed under the guidance of a dermatologist, patients often want clear information on the cost before starting
76 This finding is of interest because for many common cancers, adding molecularly targeted agents to radiotherapy can increase preclinical cure rates, 79,80,81 and currently the only targeted agent clinically approved for this application is the EGFR antagonist, cetuximab
Luba received her Master of Science in Nursing (MSN) from the University of Tennessee in 2006
Lumecca is primarily used for lightening skin on the face, but its also suitable for treating the neck, shoulders, chest, hands, arms, and legs